WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Physical mapping of complex genomes    
United States Patent5219726   
Link to this pagehttp://www.wikipatents.com/5219726.html
Inventor(s)Evans; Glen A. (Encinitas, CA)
AbstractMethod for simultaneous identification of overlapping cosmid clones among multiple cosmid clones and the use of the method for mapping complex genomes are provided. A library of cosmid clones that contains the DNA to be mapped is constructed and arranged in a manner such that individual clones can be identified and replicas of the arranged clones prepared. In preferred embodiments, the clones are arranged in a two dimensional matrix. In such embodiments, the cosmid clones in a row are pooled, mixed probes complementary to the ends of the DNA inserts int he pooled clones are synthesized, hybridized to a first replica of the library. Hybridizing clones, which include the pooled row, are identified. A second portion of clones is prepared by pooling cosmid clones that correspond to a column in the matrix. The second pool thereby includes one clone from the first portion pooled clones. This common clone is located on the replica at the intersection of the column and row. Mixed probes complementary to the ends of the DNA inserts in the second pooled portion of clones are prepared and hybridized to a second replica of the library. The hybridization pattern on the first and second replicas of the library are compared and cross-hybridizing clones, other than the clones in the pooled column and row, that hybridize to identical clones in the first and second replicas are identified. These clones necessarily include DNA inserts that overlap with the DNA insert int he common clone located at the intersection of the pooled row and pooled column. The DNA in the entire library may be mapped by pooling the clones in each of the rows and columns of the matrix, preparing mixed end-specific probes and hybridizing the probes from each row or column to a replica of the library. Since all clones in the library are located at the intersection of a column and a row, the overlapping clones for all clones in the library may be identified and a physical map constructed. In other preferred embodiments, the cosmid clones are arranged in a three dimensional matrix, pooled and compared in threes according to intersecting planes of the three dimensional matrix. Arrangements corresponding to geometries of higher dimensions may also be prepared and used to simultaneously identify overlapping clones in highly complex libraries with relatively few hybridization reactions.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 5219726
Physical mapping of complex genomes - US Patent 5219726 Drawing
Physical mapping of complex genomes
Inventor     Evans; Glen A. (Encinitas, CA)
Owner/Assignee     The Salk Institute for Biological Studies (San Diego, CA)
Patent assignment
All assignments
Publication Date     June 15, 1993
Application Number     07/360,254
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     June 2, 1989
US Classification     435/6 435/252.3 436/94 436/501
Int'l Classification     C12Q 001/68 C12N 001/20 G01N 033/566 G01N 033/48
Examiner     Yarbrough; Amelia Burgess
Assistant Examiner     Zitomer; Stephanie W.
Attorney/Law Firm     Fitch, Even, Tabin & Flannery
Address
Parent Case    
Priority Data    
USPTO Field of Search     435/6 435/91 435/320.1 536/26 536/27 536/28 536/29 935/77 935/78
Patent Tags     physical mapping complex genomes
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
4766072
Jendrisak
435/91.3
Aug,1988

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


I claim:

1. A method for simultaneous identification of overlapping cosmid clones among multiple cosmid clones, comprising:

(a) arranging the multiple cosmid clones, whereby each clone may be identified and replicas of said arrangement may be generated;

(b) pooling a first portion of the multiple cosmid clones and synthesizing mixed end-specific RNA probes from the DNA inserts that have been prepared from said pooled clones, wherein said portion includes less than all of said multiple cosmid clones;

(c) hybridizing the probes to a replica of said arranged cosmid clones and identifying the cosmid clones in the replica that hybridize to the probes, wherein said identified clones include the pooled cosmid clones and cosmid clones that contain DNA inserts that overlap with the DNA inserts in the pooled clones;

(d) repeating said hybridization step with a second portion of mixed end-specific probes that are prepared from a second pooled portion of multiple cosmid clones; and

(e) identifying the cosmid clones in each replica to which both the probes of steps b) and d) hybridize thereby identifying overlapping clones.

2. The method of claim 1, wherein said second portion includes at least one clone that was present in the first portion.

3. The method of claim 1, wherein one clone from said first portion is added to said second portion of pooled clones prior to preparing probes therefrom, whereby the clones that hybridize to both portions of probes, other than those that include the DNA inserts from which the probes were synthesized, contain DNA inserts that overlap with said added clone from the first portion.

4. The method of claim 1, further comprising:

(f) repeating said hybridization step with an additional portion of mixed end-specific probes that are prepared from an additional portion of the pooled multiple clones, wherein said additional portion includes at least one clone that was present in the first and second portions, but does not include any other clones that were previously pooled; and

(g) identifying the cosmid clones in the library to which the probes of steps b), e), and f) hybridize, wherein the identified clones are other than those which correspond to the pooled clones.

5. The method of claim 4, further comprising:

(h) repeating steps (f) and (g) a plurality of times until all of the cosmid clones in the library have been pooled and hybridized to the library.

6. The method of claim 1, wherein the arrangement is a two-dimensional matrix and the clones are pooled pairwise according to the rows and columns of a two-dimensional matrix.

7. The method of claim 1, wherein the arrangement is a three-dimensional matrix and the clones are pooled according to intersecting planes of the three-dimensional matrix, wherein following hybridization the replicas are compared according to intersecting planes of the matrix.

8. The method of claim 7, wherein groups of three replicas produced by hybridizing probes prepared from pooled clones according to three intersecting planes are compared, whereby the clones on all three replicas that hybridize to probes from each of the pooled clones include DNA that overlaps with the clone that occurs at the intersection of the three planes.

9. The method of claim 1, wherein said cosmid clones include sequence of nucleotides flanking at least one end of the inserted DNA that serve as promoters for the synthesis of the end-specific probes.

10. The method of claim 9, wherein said at least one of the flanking sequences includes a sequence of nucleotides that is recognized as a promoter by a bacteriophage polymerase, and that is positioned operatively for transcription of the inserted DNA fragment.

11. The method of claim 10, wherein both flanking sequences include sequences of nucleotides that are recognized as promoters by a bacteriophage RNA polymerase, wherein said promoters are oppositely oriented and positioned operatively for transcription of the inserted DNA fragment.

12. The method of claim 11, wherein each of the bacteriophage RNA polymerase-specific promoters is selected from the group consisting of promoters specific for bacteriophage T7 RNA polymerase, and promoters specific for bacteriophage T3 RNA polymerase.

13. The method of claim 9, wherein said cosmid clones are prepared by inserting DNA fragments into the cloning sites of a cosmid vector selected from the group consisting of pWE8, pWE10, pWE15, and PWE16.

14. The method of any one of claims 10 through 12, wherein said cosmid clones include at least two cos sites.

15. The method of claim 9, wherein said cosmid clones are prepared by inserting DNA fragments into the cloning sites of a cosmid vector selected from the group consisting of sCOS-1, sCOS-2, and sCOS-4.

16. A method for physical mapping of complex genomes comprising:

(a) preparing a genomic library of cosmid clones by inserting DNA fragments from said genome into cosmid vectors, wherein the cosmid vectors include sequences of nucleotides that flank at least one end of the inserted DNA and that serve as transcription initiation sites for the synthesis of end-specific probes;

(b) arranging the cosmid clones, whereby each clone may be identified and replicas of said arrangement may be generated;

(c) pooling portions of cosmid clones and synthesizing pools of mixed end-specific probes from the DNA inserts that have been prepared from said pooled clones, wherein each pool contains fewer than all of the cosmid clones in the library but all of the cosmid clones in the library are included in at least one pool;

(d) hybridizing each pool of probes to a replica of said arranged cosmid clones and identifying the cosmid clones in each replica that hybridize to the probes, wherein said identified clones include the pooled cosmid clones and cosmid clones that contain DNA inserts that overlap with the DNA inserts in the pooled clones;

(e) identifying the cosmid clones from among those identified in step (d) the clones that hybridize to two or more pools of probes, thereby identifying groups of cosmid clones that include overlapping DNA; and

(g) assembling contigs from said groups into a physical map of the genome from which the library was derived.

17. The method of claim 16, wherein each portion includes at least one common clone that was present in one of the other portions, whereby the clones identified in step (e) contain DNA inserts that overlap with the common clone.

18. The method of claim 16, wherein in step (e) the cosmid clones in each replica that include clones that hybridize to two or more pools are identified by comparing pairs of replicas produced by hybridizing pools that include one clone in common.

19. The method of claim 16, wherein the location of each individual clone in the replica is identified by unique coordinates that describe the location of the clone in the replica.

20. The method of claim 16, wherein the arrangement is a matrix, and the location of each clone int he matrix is uniquely identified by at least two coordinates.

21. The method of claim 20, wherein the clones whose locations include one or more common coordinates and at least one different coordinate are pooled in step (c).

22. The method of claim 16, wherein said cosmid vectors contain at least one promoter specific for a bacteriophage RNA polymerase and a cloning site for the insertion of DNA fragments, wherein aid promoter is positioned operatively for transcription of a DNA fragment into said cloning site.

23. The method of claim 22, wherein said cosmid vectors contain two oppositely oriented promoters, each of which is specific for a bacteriophage RNA polymerase and is positioned operatively for transcription of a DNA fragment inserted into said cloning site.

24. The method of claim 23, wherein each of said bacteriophage RNA polymerase-specific promoters is selected from the group consisting of promoters specific for bacteriophage T7 RNA polymerase, and promoters specific for bacteriophage T3 RNA polymerase.

25. The method of claim 24, wherein said cosmid vector is selected from the group consisting of pWE8, pWE10, pWE15, and pWE16.

26. The method of any one of claims 17 through 20, wherein said cosmid vectors contain at least two cos sites.

27. The method of claim 26, wherein said cos sites are separated by unique restriction sites.

28. The method of claim 27, wherein said cosmid vector is selected from the group consisting of sCOS-1, sCOS-2, and sCOS-4.
 Description Submit all comments and votes
 


RELATED APPLICATIONS

This application is related to the patent application U.S. Ser. No. 039,509, filed Apr. 17, 1987 and its continuation-in-part application U.S. Ser. No. 181,836, filed Apr. 15, 1988, both of which are expressly incorporated herein by reference.

FIELD OF THE INVENTION

The present invention relates to a method of recombinant DNA technology. More particularly, the invention concerns a process for physical mapping of large complex genomes, including human chromosomes. The process ("multiplex analysis") is an alternate strategy for "bottom-up" mapping, and depends on the use of cosmid vectors containing endogenous bacteriophage promoters to allow for the identification of overlapping clones by hybridization with RNA probes synthesized directly from the DNA fragments inserted therein. Since the recognition of overlaps is not based on pattern recognition, analysis may be carried out simultaneously on cosmid clones grouped together.

BACKGROUND OF THE INVENTION

The complete analysis of large complex genomes, such as genomes of higher eukaryotes, including human, requires the extensive isolation, purification and analysis of large fragments of DNA by cloning, generally in E. coli. In the past, the lambda bacteriophage cloning system has been used most frequently to generate genomic libraries. The lambda bacteriophage vectors usually accommodate inserts up to about 20 kb. Presently the primary system used to clone and manipulate large DNA fragments is that of cosmid vectors. Cosmid vectors allow the packaging of DNA fragments of up to about 45 kb in plasmids containing bacteriophage cos sites for in vitro packaging.

The analysis of complex genomes involves the application of both "top-down" and "bottom-up" mapping strategies. The "top-down" strategy depends on the separation on pulsed field gels of large DNA fragments generated using rare restriction endonucleases for physical linkage of DNA markers and the construction of long-range maps [Schwartz et al., Cell 37, 67 (1984); Southern et al., Nucleic Acids Res. 15, 5925 (1987); Burke et al., Science 236, 806 (1987)] The "bottom-up" strategy depends on identifying overlapping sequences in a large number of randomly selected bacteriophage or cosmid clones by unique restriction enzyme "fingerprinting" and their assembly into overlapping sets of clones. "Top down" mapping is inherently more rapid and less labor intensive but does not generate sets of DNA clones for further structural or biological analysis. "Bottom-up" mapping generates the required sets of overlapping clones but application of current strategies and pattern matching algorithms to mammalian genomes will require the analysis of thousands to tens of thousands of individual clones for the generation of complete maps.

In the past few years, "bottom-up" mapping strategies have been successfully applied to generate complete or partial genomic maps of E. coli, C. elegans and S. cerevisiae.

Olson et al., Proc. Natl. Acad. Sci. USA 83, 7826 (1986), fingerprinted 5000 randomly selected lambda clones containing inserts of about 15 kb of genomic DNA from S. cerevisiae, by measuring the restriction fragment lengths obtained upon double digestion with EcoRI and HindIII. They used a pattern matching algorithm to construct overlapping sets of clones (contigs) extending over about 60% of the S. cerevisiae genome.

Coulson et al., Proc. Natl. Acad. Sci. USA 83, 7821 (1986) adopted a somewhat different methodology to construct a physical map of the genome of Caenorhabditis elegans, a nematode having a genome of approximately 8.times.10.sup.7 base pairs. They digested cosmid DNAs with the restriction enzyme HindIII having a 6-bp specificity, filled the 5'-overhang with radioactive nucleotides, digested with the 4-bp specific enzyme Sau3A, and determined the size of the labeled fragments by electrophoresis in a sequencing gel followed by autoradiography. The mean size of the DNA inserts in the cosmid vectors was about 34 kb. Eight hundred sixty clusters of clones, totaling about 60% of the Caenorhabditis elegans genome, have been characterized.

Kohara et al., Cell 50, 495 (1987) analyzed 1025 lambda phage clones containing about 15.5-kb inserts of genomic E. coli DNA. For each clone they constructed a complete restriction map by means of eight restriction enzymes. The data for the 1025 clones were processed and sorted into 70 groups, including seven standing alone clones representing about 94% of the entire genome of E. coli.

While effective, the application of these "fingerprinting" and pattern matching strategies to mammalian genomes would require the individual analysis of tens or hundreds of thousands of clones for map construction as well as highly efficient computer algorithms for pattern recognition. Moreover, these and similar "fingerprinting" protocols require substantial amounts of overlap of 5 to 25% for the overlapping region to be detected. A theoretical analysis of "fingerprinting techniques" has suggested that the efficiency of the analysis is strongly dependent on the criteria used to declare overlaps between clones. According to Lander et al., Genomics 2, 231 (1988), the minimum detectable overlap has a major effect on the progress of the mapping project. Reducing the degree of overlap required for detection would substantially decrease the number of the clones which must be analyzed to obtain map closure.

Another way of detecting overlaps is the identification of overlapping clones by hybridization with RNA probes instead of pattern recognition. The identification of several bacteriophage-encoded RNA polymerases and the sequencing of their promoters has spawned a new technology for producing RNA probes. Cloning vectors are now available in which the promoters for a single polymerase, or for two different polymerases, lie adjacent to a cloning site. Transcription with any of the available polymerases enables one to produce large quantities of high-specific activity RNA probes which correspond to either the coding or the non-coding strands [Wahl et al., Methods in Enzymology 152, 572 (1987)].

Wahl et al., Proc. Natl. Acad. Sci. USA 84, 2160 (1987) (see also U.S. Ser. No. 181,836 filed Apr. 15, 1988) have designed special cosmid vectors for rapid genomic "walking" and restriction mapping. These vectors (designated as pWE for "walking easily") contain the transcription promoters from either bacteriophage SP6, T7, or T3 flanking a unique cloning site for the insertion of genomic DNA fragments. These vectors allow the synthesis of end-specific RNA probes directly from the DNA inserts, and are suitable for the detection of overlapping regions of several hundred bp in contiguous cosmids.

One practical limitation of cloning in cosmid vectors, including the above pWE vectors, is that most vectors require the initial preparation of very high quality genomic DNA, digestion to appropriate size range for cloning, and the careful purification of appropriately sized DNA fragments on gradients or gels [DiLella et al., Methods in Enzymology 152, 199 (1987)]. In the traditional cosmid cloning procedure, linearized cosmid vectors are dephosphorylated to avoid concatamerization, prior to ligation to the DNA fragments. Since the DNA inserts cannot be dephosphorylated, their size fractionation is unavoidable to avoid recombinational rearrangements caused by multiple inserts ligated into a single cosmid. For these manipulations, a substantial quantity of genomic DNA is required to construct a representative genomic library, and cosmid cloning has not been practical in situations where only submicrogram amounts of DNA can be isolated. Bates et al. Gene 26, 137 (1983) described cosmid vectors with two cos sites separated by a blunt-end restriction enzyme site. They found that the double cos-site vectors eliminate the need to prepare two separate cosmid arms, and the internal blunt-end restriction site prevents cosmid concatamerization. Thus, a double restriction enzyme digestion was found to be sufficient to prepare a vector for subsequent ligation with DNA fragments which were dephosphorylated to prevent their self-ligation. This technique eliminated the need to purify insert DNA of the proper size (30-45 kb).

The use of cosmid vectors with two or more cos sites has been shown to simplify the cloning procedure by eliminating complex preparation of cloning "arms" by Ehrich et al. in Gene 57, 229 (1987).

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows the vector sCOS-1 designed for cosmid multiplex analysis. The vector contains bacteriophage T3 and T7 promoters flanking a unique BamHI cloning site, NotI sites for expedited restriction mapping and excision of the insert DNA, duplicated cos sites for high efficiency microcloning, a dominant selection for transfection into mammalian cells, Amp and Kn resistance genes, and ColE1 origin of replication.

FIG. 2 illustrates the construction of cosmid vector sCOS-1. Relevant restriction sites in the precursor molecules are shown. ClaI-SalI and CalI-XhoI fragments were excised from pWE15 and pDVcos143 and purified on agarose gels. The indicated fragments were joined using T4 DNA ligase and coligation of the XhoI and SalI sites resulted in the loss of both sites in the resulting plasmids.

FIG. 3 depicts the DNA sequences of the cloning site, bacteriophage promoters and flanking restriction sites in sCOS vectors. Restriction sites and T3 and T7 promoter sequences added using synthetic oligonucleotides are shown. SfiI, NotI, EcoRI and SacII restriction sites are indicated by thin lines. The direction of transcription using T3 or T7 polymerase is indicated by the arrows and the thick lines delineate the critical nucleotides for promoter activity. The BamHI site is the cloning site into which MboI digested genomic DNA is inserted. All linkers were inserted by "linker-tailing" into the sites formed by digestion of sCOS-1 with EcoRI.

FIG. 4 illustrates the strategy for analysis of physical linkage using groups of cosmids.

A. Cosmids prepared in vector sCOS-1 or one of its derivatives can be used to synthesize end-specific probes for the detection of overlaps.

B. Cosmid clones are inoculated on the surface of a nitrocellulose or nylon filter from 96-well archive plates stored at -70 degrees. Each clone on the "grid" is assigned a unique identifying Y and X axis coordinate. Individual clones in the collection contain the innate capacity of generating probes specific for the extreme ends of the genomic DNA insert and detecting overlapping clones on the filter. The arrows show the locations of potential overlapping clones detected by hybridization of probes generated from the clone at coordinates Y=2, X=7.

C. and D. To enable analysis of multiple clones simultaneously, cosmids are pooled according to the rows and columns of the matrix, DNA prepared and a mixed RNA probe synthesized. When hybridized to the matrix filter, the probe detects a pattern of spots consisting of all of the template clones and the collection of clones overlapping with one end of each of the template clones. A similar procedure is carried out using cosmids pooled according to columns of the matrix. When the two data sets are compared, hybridizing clones identified by both of the mixed probes may be overlapping with the template clone common to both sets: that clone located at the intersection of the row and column. This procedure may then be repeated using other combinations of pooled probes and either T7 or T3 polymerase. The arrows denote the location of a clone which overlaps with the "T7 end" of the clone at coordinates Y=2, X=4.

FIG. 5 shows the cosmid multiplex analysis of a collection of cosmids mapping to the long arm of human chromosome 11.

A. Multiplex analysis of human cosmid clones arrayed in a 36.times.36 matrix and hybridized with a mixed probe consisting of RNA transcripts from clone of a row of the matrix. A portion of the filter is shown.

B. A portion of the filter shown in A hybridized with a mixed probe representing a pool of all cosmids aligned along a column of the matrix. The arrow identifies a cosmid clone which hybridizes with both mixed probes and is linked to the clone located at the intersection of the row and column from which probe mixtures were prepared.

FIG. 6 shows predicted contigs from human chromosome 11q and restriction enzyme digestion analysis.

A. Predicted linkage and orientation of a representative cosmid contig generated by multiplex analysis of the chromosome 11q cosmid set and data analysis using the computer program "Contig-maker". The computer output indicates the coordinates of linked clones (X,Y) and the arrows denote the orientation of the linkage.

B. Restriction map and location of probes used to establish unequivocal overlap of the cosmids. A restriction map of the overlapping clones detected in A was determined by the analysis of partial EcoRI digestion products hybridized with .sup.32 P-labeled T3 or T7 promoter-specific oligonucleotides. Overlapping areas not confirmed by restriction map analysis were confirmed by hybridization analysis using end-specific RNA probes generated from individual cosmid clones. Cosmid clones c14,23 and c19,27 are identical. .quadrature. indicates bacteriophage T3 promoter, bacteriophage T7 promoter.

SUMMARY OF THE INVENTION

The present invention relates to a rapid and powerful method for "bottom-up" mapping that is applicable to mammalian chromosomes and allows for the simultaneous analysis of multiple cosmid clones for the detection of overlaps. The method, called "cosmid multiplex analysis", depends on the use of cosmid vectors allowing for the synthesis of corresponding RNA sequences (probes) specific to the extreme ends of the DNA fragments inserted therein, directly from the DNA inserts. In this way, rather than depending on "fingerprinting" procedures for detection of overlapping clones, cosmid libraries are constructed using vectors containing at least one bacteriophage promoter adjacent to the genomic DNA insert, positioned operatively for the transcription thereof. Preferably, the cosmid vectors contain two bacteriophage promoters flanking the DNA fragment ligated into the insertion site. Synthesis of an end-specific RNA probe from any clone in the collection allows the overlapping clones to be easily detected by hybridization. Because this strategy does not depend on pattern recognition for detecting overlaps, analysis may be carried out simultaneously on cosmid clones grouped together. The method is suitable for the unambiguous detection of overlapping regions as small as several hundred nucleotides in contiguous cosmids. Accordingly, the number of clones needed for map closure can be reduced by up to three-fold. Finally, this strategy represents essentially simultaneous cosmid "walking" and thus is basically non-random, allowing the investigator the freedom to pause and investigate some interesting biology rather than requiring completion of the map before it becomes useful.

In one aspect, the present invention relates to a process for simultaneous analysis of multiple cosmid clones, comprising:

(1) synthesizing mixed end-specific RNA sequences directly from DNA templates prepared from groups of cosmid clones pooled together,

(2) hybridizing the mixed end-specific RNA sequences derived from individual groups of cosmid clones to a replica of all cosmid clones to be analyzed, whereby a data set of hybridization spots corresponding to all of said DNA templates and the collection of DNAs overlapping with one end of each of the DNA templates is identified,

(3) identifying cross-hybridizing clones which are common to two or more data sets.

In a preferred embodiment, the cross-hybridizing clones are identified by pairwise comparison of data sets obtained from two groups of cosmid clones containing at least one common clone. The cosmid clones are preferably pooled according to the rows and columns of a two-dimensional matrix.

In a further aspect, the invention relates to a process for physical mapping of complex genomes, comprising:

(1) generating a genomic library of clones in cosmid vectors allowing for the synthesis of end-specific RNA sequences directly from at least one end of a DNA fragment inserted therein,

(2) providing groups of cosmid clones pooled together,

(3) synthesizing mixed end-specific RNA sequences directly from DNA templates prepared from said groups of cosmid clones,

(4) hybridizing the mixed end-specific RNA sequences derived from individual groups of cosmid clones to a replica of all cosmid clones to be analyzed, whereby a data set of hybridization spots corresponding to all of said DNA templates and the collection of DNAs overlapping with one end of each of the DNA templates is identified,

(5) identifying cross-hybridizing clones which are common to two or more data sets, and

(6) assembling contigs of said cross-hybridizing clones.

In a preferred embodiment, the cosmid vectors used in the above processes comprise two oppositely oriented promoters, each of which is specific for a bacteriophage RNA polymerase, positioned on two sides of the cloning site. Most preferably, the vectors contain T3 and T7 endogenous bacteriophage promoters flanking the cloned genomic DNA. Vectors containing at least two cos sites are particularly preferred, since they allow the use of DNA fragments without previous size separation.

From the list of linked clones produced by this technique, contigs can be assembled either manually or through computer analysis of the data.

DETAILED DESCRIPTION OF THE INVENTION

Definitions

"Genomic library" is a mixture of clones constructed by inserting fragments of genomic DNA into a suitable vector. The term "library" implies the existence of large numbers of different recombinants out of which only a few are of immediate interest to the investigator.

The terms "cosmid" and "cosmid vector" and grammatical variations thereof, are used interchangeably and refer to plasmid vectors that contain a lambda bacteriophage cos (cohesive end) site. The lambda bacteriophage packaging system selects DNA molecules of about the size of the lambda genome (37-52 kb). Accordingly, plasmid recombinant DNA having a minimum size of about 38 kb and a maximum size of about 52 kb (about 78% and about 105% of phage lambda, respectively), can be packaged in vitro in the lambda phage coat. In addition to the cos site(s) cosmid vectors usually contain a marker gene allowing for selection in bacteria (antibiotic resistance gene), and one or more unique restriction sites for cloning. Plasmids with a large variety of cloning sites and prokaryotic and eukaryotic selection markers can be converted to cosmids by insertion of the lambda cos region.

The term "plasmid" refers to circular, double-stranded DNA loops which in their vector form, are not bound to the chromosome.

As used herein, the term "a promoter specific for a bacteriophage RNA polymerase" means a wild-type or non-wild-type promoter that can be used by the bacteriophage RNA polymerase for in vitro transcription of a DNA fragment. When a non-wild-type promoter is used for such in vitro transcription of a DNA fragment, transcription will occur at a rate which is at least 10% of the rate at which transcription would have occurred if a wild-type or native promoter had been used by the bacteriophage RNA polymerase to transcribe the DNA fragment in vitro.

The term "cloning site" as used herein, means restriction endonuclease site on the DNA sequence of the cosmid vectors of the present invention where a DNA fragment can be inserted without deleting any of the original DNA.

The term positioning a promoter "operatively for transcription of a DNA fragment" as used herein, means that the promoter will be positioned in such a way that any DNA sequences between the promoter's transcriptional start site and the DNA fragment will not prevent transcription of at least a portion of the DNA fragment by the promoter. The term "at least a portion" means that preferably at least 8bp and more preferably at least about 30 bp of the DNA fragment will be transcribed.

The terms "end-specific RNA sequences", "RNA probes", and grammatical variations thereof, are used to refer to hybridization probes obtained by transcription of corresponding DNA fragments.

Clones are overlapping if they contain contiguous DNA in the same relationship as that in the genome. One method for detecting overlaps is to synthesize an RNA probe from one end of a first clone. If this probe detectably hybridizes with an end of the second clone under standard hybridization conditions, the two clones are overlapping [Wahl et al., PNAS USA 84, 2160 (1987)].

The term "contig" was introduced by Rodger Staden, Nucleic Acids Res. 8, 3673 (1980) in connection with DNA sequence analysis, and refers to groups of clones with contiguous nucleotide sequences.

Materials and General Methods

Unless otherwise stated, the present invention was performed using standard procedures, as described, for example in Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., USA (1982); Davis et al., Basic Methods in Molecular Biology, Elsevier Science Publishing, Inc., New York, USA (1986); or Methods in Enzymology: Guide to Molecular Cloning Techniques Vol. 152, S. L. Berger and A. R. Kimmerl Eds., Academic Press Inc., San Diego, USA (1987).

Cell lines

TG 5D1-1 is a Friend cell line derived from somatic cell hybrid 5D1 that carried an intact human X chromosome 11 [Pyati et al., Proc. Natl. Acad. Sci USA 77, 3435 (1980)], and was selected for the loss of the entire X chromosome and most of chromosome 11. TG 5D1-1 contains the distal portion of chromosome 11 as the only human material in a mouse genomic background [Maslen et al., Genomics 2, 66 (1988)]. Cytogenetic and molecular analysis indicates that the amount of human DNA represented about 1% of the mouse genomic background [Maslen et al., Supra].

Bacterial Strains

Cosmid vectors were replicated in E. coli strain DH5, a derivative of the strongly recA. strain DH1 (commercially available, e.g. from Bethesda Laboratories, Gaithersburg, Md., USA), in AG1 (Stratagene Cloning Systems, San Diego, Calif.) a derivative of DH5 selected for high packaging efficiency, or in HB101 (commercially available, e.g. from Bethesda Laboratories, Gaithersburg, Md., USA).

Cosmid Vectors

Genomic libraries were constructed in cosmid vector sCOS-1 illustrated in FIG. 1. sCOS-1 was prepared from cosmid vectors pWE15 [Evans et al., Methods in Enzymology 152, 604 (1987) and U.S. Ser. No. 181,836, ATCC Accession No. American Type Culture Collection (ATCC), 12301 Parklawn Drive, Rockville, Md. 20852 U.S.A. 37503] and pDVcos134 [a gift from J. Reese, in wide circulation among scientists] as shown in FIG. 2. pWE15 DNA was digested with ClaI and SalI, and the 6 kb ClaI-SalI restriction fragment, lacking the cos sequence was purified. Cosmid pDVcos134 was digested with ClaI and XhoI and a restriction fragment containing the duplicated cos region was purified on a low melting point agarose gel. The purified fragments were ligated using T4 DNA ligase and transformed into E. coli host strain DH5.

Other pWE plasmids suitable for genomic mapping according to the invention are disclosed in Evans et al., Methods in Enzymology, Supra and U.S. Ser. No. 181,836. Cosmid vector pWE16 has been deposited with the American Type Culture Collection, and has been accorded ATCC No. 37524.

Cosmids sCOS-2 and sCOS-4 are derivatives of sCOS-1 where the cloning site has been altered to substitute other rare restriction sites for the NotI sites. Cosmid vector sCOS-2 was constructed by digesting sCOS-1 with EcoRI, and purifying the plasmid DNA away from the NotI-T3 promoter-BamHI-T7 promoter-NotI linker sequence by ethanol precipitation. A 30-nucleotide double-stranded synthetic oligomer with EcoRI coadhesive ends, containing NotI-T3 promoter-BamHI-T7 promoter-Sac2 sequences was added by linker-tailing [Lathe et al., DNA 3, 173 (1984)]. sCOS-4 was constructed using a similar procedure adding a double-stranded synthetic oligonucleotide containing EcoTI coadhesive ends and a SfiI-T3 promoter-BamHI-T7 promoter-SfiI sequence. The sequences of the linker-cloning promoter sequences of sCOS vectors are shown in FIG. 3.

Construction of Cosmid Libraries In sCOS Vectors

High molecular weight genomic DNA for cosmid cloning was prepared by proteinase k digestion and gentle phenol extraction followed by dialysis [DiLella et al., Methods in Enzymology 152, 199 (1987)]. The average molecular size of the isolated DNA was determined using field inversion gel electrophoresis [Carle et al., Science 232, 65 (1986)] and ranged from about 500 kb to greater than 3 mb. DNA was digested with MboI under conditions recommended by the manufacturers and the digestion terminated by phenol/chloroform extraction. Following digestion, the DNA was analyzed on field inversion gels or 0.3% agarose gels to determine the average size of the digestion products. For the construction of genomic libraries in cosmid vector sCOS-1 genomic DNA was digested to an average size of 100-120 kb, and dephosphorylated with calf intestinal phosphatase. The genomic DNA was not size separated before cloning.

Vector cloning arms were prepared by first digesting purified sCOS vector DNA with XbaI followed by dephosphorylation with calf intestinal alkaline phosphatase. The reaction was terminated by phenol/chloroform extraction and the DNA collected by ethanol precipitation. The linearized, dephosphorylated vector DNA was then digested with BamHI, extracted with phenol/chloroform and stored at a concentration of 1 mg/ml in 20mM TRIS.HCl, pH.6, 1 mM EDTA. Ligations were performed using 1 .mu.g of vector arms and 50 ng to 3 .mu.g of genomic DNA. Reactions were incubated with 2 Weiss Units of T4 DNA ligase and packaged using commercial in vitro packaging lysates. Bacteriophage lambda packaging extracts may contain significant amounts of EcoK restriction activity. To avoid the possibility that mammalian sequences containing an EcoK site might be underrepresented in the library, genomic libraries are prepared using in vitro packaging extracts which lack EcoK restriction activity (e.g. Gigapak-Gold; Stratagene Cloning Systems, San Diego, Calif.).

Cosmid libraries were plated directly on LB agar containing 25 .mu.g/ml of kanamycin sulfate and libraries screened without further amplification [Evans et al., Methods in Enzymology 152, 604 (1987)]. Libraries were stored as original non-amplified plate stocks in LB media with 15% glycerol at a concentration of 2.2.times.10.sup.11 bacteria/ml at -70 degrees. The cosmid library used in the study described in the examples consisted of 1.5.times.10.sup.7 independent clones.

Selection of Human Clones from a Somatic Cell Hybrid Genomic Library

Cosmid libraries were plated on 570 cm.sup.2 LB agar trays at a density of 10 clones/cm.sup.2, replica filters prepared and filters hybridized with human placenta DNA labeled with .sup.32 P-dCTP to a specific activity of 10.sup.8 cpm/.mu.g. Under these hybridization conditions, no background hybridization was detected against cosmids carrying mouse genomic DNA. Cosmids containing human genomic DNA inserts were picked with toothpicks, rescreened by hybridization to .sup.32 P-labeled human DNA, and archived in 96-well microtitre plates containing LB media, 15% glycerol and 25 .mu.g/ml kanamycin sulfate at -70 degrees. Individual clones isolated from cosmid libraries were routinely grown, replicated, and DNA prepared using standard round-bottom 96-well microtitre plates. Replica transfer of clones in 96-well microtitre plates and transfer from archived plates to screening filters was carried out using an aluminum "hedgehog" made from 3-mm diameter brass rods set in plastic block, as described by Coulson et al., Supra (p. 7822), or a laboratory robot (Beckman Biomek 1000).

Plating and Screening Libraries

For multiplex analysis, archived cosmids were inoculated on the surface of a nitrocellulose or nylon based filter in a matrix or "grid" pattern. The size and density of the "grid" was determined by the pattern of wells in a standard 96-well microtitre plate and, in the experiments described in the examples, a 36.times.36 matrix was used. Before applying bacterial culture, a matrix pattern prepared on paper was transferred directly to the filter membrane by passing the filter through a copying machine followed by autoclaving. The clones were allowed to grow on the surface of the filter at 37 degrees for 12 to 15 hours and bacterial DNA was fixed to the filter using a standard colony lysis procedure [Vogeli et al., Methods in Enzymology 152, 407 (1987)].

RNA Probe Synthesis and Hybridization Reactions

Cosmids were transferred from archives to fresh 96-well plates containing liquid LB media with 25 .mu.g/ml kanamycin sulfate and incubated at 37 degrees in a humidified atmosphere for 6 to 10 hours. Supernatants from individual wells were pooled and DNA prepared using a previously described cosmid miniprep procedure [Evans et al., Methods in Enzymology, Supra]. Cosmids constructed with vector sCOS-1, or one of its derivatives, yield up to 2 .mu.g of DNA from a 300 .mu.l culture and all probe synthesis and mapping reactions were carried out with DNA prepared from minilysates. In some cases, the pooled DNA was digested with a restriction endonuclease such as BamHI or HindIII prior to probe synthesis. RNA probes were synthesized as in patent applications U.S. Ser. Nos. 039,509 and 181,836 described, using bacteriophage T3 or T7 polymerase (Stratagene Cloning Systems, San Diego, Calif., USA). Briefly, cosmid DNA was prepared and 1-2 .mu.g of the DNA was transcribed with T7 or T3 RNA polymerase in a 20 .mu.l reaction, as described by Melton, et al. (1984) Nucleic Acids Res. 12: 7035-7054, using 50 .mu.Ci of [.alpha.-.sup.32 P] UTP and 12 .mu.M unlabeled UTP. .sup.32 P-UTP and polymerase reactions were terminated by extraction with phenol and chloroform. 100 .mu.l of blocking mixture (a mixture of sonicated human placenta DNA and cloned human repetitive sequences at a concentration of 1 mg/ml) was added, and the probe mixture was precipitated with ethanol. The nucleic acid was then resuspended in 20 .mu.l of 5X SSPE, 0.1% SDS, and prehybridized for 5 minutes at 42 degrees to saturate repetitive sequences which might be present in the probe. The probe was then added to a plastic bag containing a replica of the matrix filter and hybridization buffer [5X SSPE, 50% formamide, 0.2% SDS, 1.times. Denhardt's solution (D. Denhardt, Biochem. Biophys. Res. Commun. 23, 641 (1966)), and 20 .mu.g/ml salmon sperm DNA] and the hybridization reaction carried out for 12 to 18 hours. Filters were washed in 0.1.times. SSPE, 0.1% SDS, at 65 degrees and exposed to X-ray film for 2 to 8 hours.

Restriction Enzyme Analysis

Restriction enzyme analysis of isolated cosmids was carried out using DNA isolated from minilysates. Cosmid DNA was prepared from minilysates as follows:

DNA was isolated from 1.5 ml cultures. A culture was inoculated with a single bacterial colony and incubated with vigorous shaking at 37 degrees for 6 hours. DNA was prepared using a modified boiling procedure [Evans et al., Methods in Enzymology 152, 604 (1987)]. Cells were collected by a brief (1 min.) centrifugation in a microcentrifuge and cells were resuspended in 300 .mu.l of STET buffer. 20 .mu.l of freshly prepared lysozyme (10 mg/ml) in STET buffer were added, the mixture vortexed and incubated in a boiling water bath for one minute. The solution was immediately centrifuged for 10 minutes in a microcentrifuge and the gelatinous pellet removed with a toothpick and discarded. 325 .mu.l of isopropanol were added and the mixture incubated at room temperature for 5 minutes. The precipitated DNA was collected by centrifugation at room temperature in a microcentrifuge, the pellet dried and resuspended in water.

DNA was digested to completion with NotI, digested partially with one or more enzymes (typically BamHI, EcoHI, HindIII, SacII, PvuII, and KpnI), separated on an agarose gel, transferred to a nitrocellulose filter and hybridized with .sup.32 P-labeled oligonucleotides recognizing the T3 or T7 bacteriophage promoters. T3 and T7 oligonucleotides (commercially available as sequencing primers, Stratagene Cloning Systems, San Diego, Calif., USA) were labeled using polynucleotide kinase and .gamma.-.sup.32 P ATP to a specific activity of 2.times.10.sup.8 cpm/.mu.g. The labeled oligonucleotides were then hybridized to the filters in 6.times. SSC, 10% Denhardt's solution for 12 hours at 42 degrees and washed in 2.times. SSC for 10 minutes at 50 degrees. Filters were exposed to X-ray film for 20 minutes to 12 hours. The pattern of bands appearing on the autoradiograph could then be interpreted as indicating the distance from the cloning site to the restriction site, much as with the "cos"-mapping procedure of Rackwitz et al., Gene 30, 195 (1984).

Alternatively, programmed automatic restriction enzyme digestions were carried out to completion in 96-well microtitre plates using a laboratory robot (Beckman Biomek 1000).

Data Analysis

The resulting hybridization data were manually entered into a computer file and analyzed using two computer programs written by G. A. Evans in Turbo Pascal (Borland International) running on Apple Macintosh II or Macintosh SE computers. One program "Multiplex-mapper" compared data sets from hybridization reactions using mixed probes, determined those clones which were identified by more than one probe mixture, and produced a list of linked clones. A second program, "Contig-maker" assembled the list of overlapping clones into potential contigs which could be analyzed in greater detail. In some cases, orientation and overlap of individual cosmid clones in a contig were confirmed by detailed restriction mapping and hybridization analysis of the individual cosmid clones.

Although data analysis was performed using the above-mentioned computer programs, a person of ordinary skill in the art should have no difficulty in carrying out the comparison of data and assembling the overlapping clones into contigs using other software. Moreover, manual data comparison and contig making are also possible, though more laborious.

LB media 10 g Bacto-tryptone, 5 g yeast extract, 5 g NaCl per lit. of water. Autoclave.

LB agar LB media containing 1.2% Bacto-agar. Autoclave.

STET buffer 50 mM TRIS.HCl, pH 8.0, 8% sucrose, 5% Triton X-100 and 50 mM EDTA

Denhardt's solution 0.2% Ficoll, 0.2% polyvinyl pyrrolidone, 0.2% bovine serum albumin

Abbreviations

SDS: sodium dodecyl sulfate

SSPE: saline sodium phosphate EDTA

SSC: saline sodium citrate

DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention relates to a new approach for "bottom-up" genomic mapping using cosmid clones. It has been found that significant improvements in the speed and efficiency of "bottom-up" genomic mapping can be achieved, by 1) isolating restricted regions of large mammalian genomes in a "sublibrary" preorganized on a solid matrix, 2) using hybridization of end-specific probes for detection of overlapping clones in the collection, rather than "fingerprinting" followed by pattern recognition, and 3) analyzing multiple clones simultaneously for the detection of all overlaps in the collection.

According to the invention, essentially the strategy illustrated in FIG. 4 is used for genomic mapping using cosmid vectors.

In a first step, a genomic library which represents a limited portion of a